Pune, Maharashtra -- (SBWIRE) -- 05/24/2019 -- Cancer profiling market revenues surpassed US$ 900 million in 2018, according to Fact.MR's latest study. Growing at a subdued 4% y-o-y, the study foresees absolute opportunity of over US$ 36 million in 2019. Steadily rising opportunities in cancer profiling market can be attributed to,

Increasing disease burden of cancer worldwide
Significant economic burden associated with cancer diagnosis and treatment
Growing R&D investments to develop effective cancer diagnostics
Increasing importance of precision medicine adoption and reliance of cancer profiling
According to the study, cancer profiling market revenues continue to remain consolidated in North America. Of the estimated new cases, breast cancer accounts for over 15% and colorectal cancer for about 8% new cases. As breast and colorectal cancers are few of the leading causes of death in North America, collectively they register nearly 70% of total regional cancer profiling revenues.

Request Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=358 

The study estimates that Europe represents the second most significant demand for cancer profiling and accounts for over four fifth of the global revenues. Rising incidences of cancer, EU's proactive efforts to promote cancer screening and use of best practices to improve the quality are responsible for the significant investments in cancer profiling space in Europe.

Fact.MR finds that APEJ will register significant utilization of cancer profiling in coming years on the back of rising awareness and adoption of improved tools for cancer identification.

Breast Cancer Accounts for Nearly Half the Cancer Profiling Revenues

According to the study, breast cancer is expected to take maximum advantage of cancer profiling as compared to other cancer types. After lung cancer, breast cancer is the second most leading cause of new cancer cases.

Globally, national governments are actively engaged in generating awareness regarding the prevention and diagnosis of breast cancer. As cancer profiling applications remain higher in breast cancer diagnosis, a significant fall in breast cancer mortality shows promising diagnosis and improved treatment.

Colorectal cancer is also categorized among one of the leading causes of new cancer cases and cancer deaths. The study finds that followed by breast cancer, a significant utilization of cancer profiling can be observed in colorectal cancer.

Browse Full Report @ https://www.factmr.com/report/358/cancer-profiling-market 

Cancer profiling constitutes utilization of multiple technologies, of which immunohistochemistry (IHC) and Fluorescent In Situ Hybridization (FISH) are the most reliable technologies preferred by oncologists. Fact.MR reveals that FISH systems register leading revenues in the cancer profiling market, followed by IHC. FISH is the most commonly used technique for cancer profiling among researchers and for cancer diagnosis. Lower cost and higher sensitivity of IHC can be attributed to its significant adoption in cancer profiling.

Fact.MR study estimates that hospitals account for a significant share of the cancer profiling market followed by diagnostic centers. Increasing establishments of multi-speciality hospitals with in-house diagnostic centers are driving the growth of cancer profiling market in hospitals. A considerable utilization of cancer profiling is also found in research laboratories and cancer research institutes.

The cancer profiling marketplace is marked by hefty investments oriented at robust biomarker development to expand cancer profiling capabilities. Lengthy clinical trials present another milestone wherein tedious authorization process of FDA engages significant investments of stakeholders.

The Fact.MR report tracks the cancer profiling market for the period 2018-2028. According to the report, the cancer profiling market is projected to grow at 4.7% CAGR through 2028.

You can Buy This Report from Here @ https://www.factmr.com/checkout/358/S 

To deliver a seamless understanding of the Cancer Profiling  market, the report is divided into 18 sophisticated chapters whose snapshots are provided below.

Chapter 1 – Executive Summary
The report commences with the chapter of the executive summary which delivers brief yet affluent information of the Cancer Profiling  market. The chapter includes discussion on the market overview, market analysis and market recommendations regarding the Cancer Profiling  market derived based on Fact.MR's proprietary wheel of fortune.

Chapter 2 – Market Introduction
In the market introduction chapter, the Cancer Profiling  market is introduced along with the
market segmentation in the form of market taxonomy. The chapter also introduces the Cancer Profiling  in the market definition section.

Chapter 3 - Cancer Profiling  Market Background
In this chapter, macroeconomic factors, market dynamics, a complete value chain and pricing
analysis with regard to Cancer Profiling  market is elaborately discussed. Discussion on the
market drivers, restraints, trends and opportunities and their impact on the market forecast is also
covered in this chapter.

Chapter 4 - Global Cancer Profiling  Market Analysis 2013–2017 and Forecast 2018–2026
This chapter provides the Cancer Profiling  market size in terms of market volume and value
during the forecast period. Market analysis based on absolute $ opportunity and y-o-y growth of the Cancer Profiling  market is also covered in this chapter.

Chapter 5 - Global Cancer Profiling  Market Analysis 2013–2017 and Forecast 2018–2026,

By System Type Based on system types in the Cancer Profiling  market, the chapter elaborates market size of individual systems and analysis by system types and summary of this section is covered in the chapter.

Chapter 6 - Global Cancer Profiling  Market Analysis 2013–2017 and Forecast 2018–2026, By Application

Based on applications, Market size of individual applications, their market attractiveness analysis and summary are also covered.

Chapter 7 - Global Cancer Profiling  Market Analysis 2013–2017 and Forecast 2018–2026, By End User

This chapter elaborates the segmentation of the Cancer Profiling  market based on end users
including independent end users, Market attractive analysis by end users is also discussed to fathom relative lucrativeness of different end users of the Cancer Profiling  market.

Chapter 8 - Global Cancer Profiling  Market Analysis 2013–2017 and Forecast 2018–2026, By Region

With the geographical perspective, the Cancer Profiling  market is analyzed on a total of seven regions including North America, Latin America, Europe, South East Asia & Pacific, Middle East & Africa, China and Japan. Historical data and prevailing trends in the Cancer Profiling  market and their influence on the global market performance is discussed in this chapter.

And Continue....